香港股市 已收市

雲康集團 (2325.HK)

HKSE - HKSE 延遲價格。貨幣為 HKD。
加入追蹤清單
11.060+0.020 (+0.18%)
收市:04:09PM HKT

雲康集團

No. 9 Yayingshi Road
Science City Huangpu District
Guangzhou
China
86 20 3210 6666
https://www.yunkanghealth.com

版塊Healthcare
行業Diagnostics & Research
全職員工1,510

高階主管

名稱頭銜支付行使價出生年份
Mr. Yong ZhangChairman & CEO192.53k1972
Mr. Yingjia LinCFO & Joint Company Secretary1980
Mr. Xubo WangExecutive Vice President1975
Ms. Lok Yee Chan A.C.I.S., A.C.S.Joint Company Secretary1990
截止 2022年12月31日為止計算的金額,現金賠償則計算至上一個財政年度末止。薪資是指薪俸、獎金等。已行使價是指財政年度期間已行使的期權價值。貨幣為 HKD。

描述

Yunkang Group Limited operates as a medical operation service provider in the People's Republic of China. The company offers diagnostic testing services for medical institution alliances, including setting up or upgrading diagnostic centers, the establishment of standard operating procedures for diagnostic testing, diagnostic consultation and staff training, procurement of equipment, smart internet of things, and logistics assistance. It also provides diagnostic outsourcing services comprising pathology tests; infectious disease diagnostic tests, including hepatitis B virus, tuberculosis, human papilloma virus, EB virus, rabies virus, and nucleic acid tests for respiratory pathogens; genetic reproduction and screening tests; and routine diagnostic tests for chronic kidney, blood, autoimmune, endocrine metabolism, and other diseases. In addition, the company offers diagnostic testing services for financial institutions and insurance companies, including personalized diagnostic testing, medical report consultation, and hospital referral services; information technology, medical logistics, and medical equipment procurement; healthcare technology development; and project investment. It provides its services through independent clinical laboratories and on-site diagnostic centers. Yunkang Group Limited was founded in 2008 and is headquartered in Guangzhou, the People's Republic of China.

公司管治

截至 無 止,雲康集團 的 ISS 管治質素評分為 無。 Pillar 分數正在審核中:無;董事會:無;股東權利:無;現金賠償:無。

企業管治評分的資料提供: Institutional Shareholder Services (ISS). 評分將以 1 至 10 分顯示 (與指數或地區相關)。1 分表示較低的管治風險,而 10 分表示較高的管治風險。